Content area
Full Text
PARIS - L'Oral has acquired SkinEthic, a tissue engineering company, based in Nice, France, to further develop its alternative methods for ingredient safety evaluation and research.
Financial terms of the deal were not disclosed.
The French beauty giant bought SkinEthic through its Episkin subsidiary, which develops reconstructed skin.
"The acquisition of SkinEthic allows us to respond to the needs of the entire industry and more specifically in the area of alternative approaches to animal testing - a top priority for L'Oral," said Jean-Franois Grollier, vice president of research and development at the company, in a statement.
Added Martin Rosdy, founder of SkinEthic, also in the statement: "The acquisition provides SkinEthic with a new approach to the market and brings with it the research capability that will benefit all present and future customers."
SkinEthic produces and distributes human epidermal and epithelial tissues for in vitro tests.
More stringent legislation concerning animal testing has helped encourage cosmetics companies to find new ways to test their products' safety.
L'Oral's SkinEthic buy comes less than a week...